Defective interleukin 2 (IL2) production by peripheral blood mononuclear cells (PBMC) of bone marrow transplant recipients is not due to accessory cell or T cell receptor defects.
Cooley
M A
MA
Centre for Immunology, St Vincent's Hospital, Sydney, Australia.
McLachlan
K
K
Atkinson
K
K
D000293:Adolescent; D000328:Adult; D000938:Antigen-Presenting Cells / Q000276:immunology*; D016026:Bone Marrow Transplantation; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000096:biosynthesis*; D007963:Leukocytes, Mononuclear / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000378:metabolism; D011948:Receptors, Antigen, T-Cell / Q000172:deficiency*; D013601:T-Lymphocytes / Q000378:metabolism
D007376:Interleukin-2; D011948:Receptors, Antigen, T-Cell